Use of the immunopotentiator N-acetyl-glucosamine-N-acetylmuramyl dipeptide during triple anti-Helicobacter pylori therapy
AIM: To evaluate the efficiency of first-line Helicobacter pylori eradication therapy with glucosаminylmuramyldipeptide (Licopid JSC "Peptek", Russia). /MATERIAL AND METHODS: Eradication therapy was performed in 128 patients (84 men and 34 women; mean age 44.1±13.5 years) with duodenal bul...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
"Consilium Medicum" Publishing house
2012-12-01
|
| Series: | Терапевтический архив |
| Subjects: | |
| Online Access: | https://ter-arkhiv.ru/0040-3660/article/view/31164 |